A natural triterpenoid compound extracted from Melia volkensii nuts, formulated with food-safe adjuvants such as kaolin, offering an alternative to synthetic pyrethroid and organophosphate grain dusts. Targets stored-grain weevils (Sitophilus zeamais) and lepidopteran pests including fall armyworm (Spodoptera frugiperda) through insecticidal action and cell damage.
This solution harnesses toosendanin, a triterpenoid phytochemical naturally produced in the nuts of Melia volkensii, a tree native to Kenya. The research focuses on developing a standardized extraction method and a practical formulation, using adjuvants such as kaolin, that delivers reliable pest control while being safe for application on grain intended for human consumption. The product is positioned as a safer alternative to existing Kenyan grain dusts, which rely on organophosphates combined with synthetic pyrethroids.
The target pests include the maize weevil (Sitophilus zeamais), a major threat to stored grain, and lepidopteran larvae such as fall armyworm (Spodoptera frugiperda), which damages maize and other crops in the field. By replacing synthetic chemistries with a bio-based active ingredient, the solution addresses growing concerns over chemical residues, pest resistance, and worker safety in post-harvest and crop protection.
Active ingredient and source:
Mode of action:
Formulation approach:
Research focus areas:
The technology is at an early-to-mid research and development stage. Current work centers on establishing a reproducible extraction process, formulating a kaolin-based grain dust, and conducting initial efficacy and safety evaluations against target pests. Validation procedures and future validation plans are in progress to confirm insecticidal performance, formulation stability, and food-grain safety. Further field and storage trials will be required to advance toward commercial deployment.
The University of Nairobi is Kenya’s flagship public research university, with a large student body and comprehensive academic breadth. Located in the capital’s corporate and government hub, it offers partners rapid access to collaborators, field sites, and pilot opportunities across East Africa. Co-located labs and testbeds, integration with a major teaching hospital, and an active incubation ecosystem create clear pathways from discovery to validation and deployment. Research is supported by competitive national programs and international agencies, including major U.S. funders such as NIH and USAID. A dedicated technology transfer office and a commercialization arm deliver IP support, licensing, contract research, and consulting.